Opioid Use Treatment and Recovery Services During Pregnancy

Abstract

Background:

The maternal and neonatal consequences of not receiving treatment for opioid use disorders (OUDs) is well known. To prevent adverse outcomes and provide appropriate treatment and services, it is imperative to understand factors influencing pregnant women with OUDs to seek treatment.

Objectives:

The purpose of this study is to identify barriers and facilitators related to opioid use treatment and recovery services among pregnant and nonpregnant women who misuse opioids.

Method:

Retrospective analysis of data from the National Survey on Drug Use and Health (NSDUH), using 2016, 2017, and 2018 NSDUH data. Sample included 122 pregnant and 3,305 nonpregnant women who misused opioids.

Results:

Significant associations were noted among women who misused opioids (n = 3,427); age (χ² = 25.406, p < .001), race/ethnicity (likelihood ratio [LR] = 17.721, p < .007), geographic location (χ² = 7.585, p < .023), health insurance (LR = 13.909, p < .016), tobacco use within the past year (χ² = 7.058, p = .008), and alcohol use within the past month (χ² = 76.783, p < 0.001), 3.3% pregnant and 1.8% nonpregnant women who misuse opioids perceive a need to obtain treatment; 10.7% pregnant and 6.5% nonpregnant women currently receiving treatment for opioid misuse. The Strengthening the Reporting of Observational studies in Epidemiology checklist was used to develop the study.

Conclusions:

It is our responsibility to equally focus efforts on understanding the construct of perceived need and help seeking behaviors among pregnant women, as well as, deploy known techniques to engage them in recovery. Further research is necessary to explore the construct of perceived need in this population, as well as, strategies to increase engagement.

Keywords

opioids pregnancy National Surveys on Drug Use and Health (NSDUH)drug treatment opioid use disorder opioid misuse

Get full access to this article

View all access options for this article.

References

Ali

M. M.

Teich

J. L.

Mutter

(2015). The role of perceived need and health insurance in substance use treatment: Implications for the aﬀordable care act. Journal of Substance Abuse Treatment, 54, 14-20. https://doi.org/10.1016/j.jsat.2015.02.002

American College of Obstetricians and Gynecologists. (2017). Opioid use and opioid use disorder in pregnancy (ACOG Committee Opinion, Number 711). https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2017/08/opioid-use-and-opioid-use-disorder-in-pregnancy

Angelotta

Weiss

C. J.

Angelotta

J. W.

Friedman

R. A.

(2016). A moral or medical problem? The relationship between legal penalties and treatment practices for opioid use disorders in pregnant women. Women’s Health Issues, 26(6), 595-601. https://doi.org/10.1016/j.whi.2016.09.002

Centers of Disease Control and Prevention. (2018a). The number of women with opioid use disorder at labor and delivery quadrupled from 1999-2014. https://www.cdc.gov/media/releases/2018/p0809-women-opiod-use.html

Centers of Disease Control and Prevention. (2018b). Understanding the epidemic. https://www.cdc.gov/drugoverdose/epidemic/index.html

Choi

N. G.

DiNitto

D. M.

Marti

C. N.

(2014). Treatment use, perceived need, and barriers to seeking treatment for substance abuse and mental health problems among older adults compared to younger adults. Drug and Alcohol Dependence, 145, 113-120. https://doi.org/10.1016/j.drugalcdep.2014.10.004

Christie

Baker

Cooper

Kennedy

P. J.

Madras

(2017). The President’s Commission on Combating Drug Addiction and the Opioid Crisis. https://facesandvoicesofrecovery.org/wp-content/uploads/2019/06/Final-Report-The-Presidents-Commission-on-Combatting-Drug-Addiction-and-The-Opioid-Crisis.pdf

Criminal Justice Policy Foundation. (n.d.). Drug policy. https://www.cjpf.org/drug-policy/#_ftn1

Drug Policy Alliance. (2017). It’s time for the U.S. to decriminalize drug use and possession. http://www.drugpolicy.org/resource/its-time-us-decriminalize-drug-use-and-possession

10.

Drug War Facts. (2018). http://www.drugwarfacts.org/chapter/crime_arrests

11.

Florence

C. S.

Zhou

Luo

(2016). The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013. Medical Care, 54(10), 901-906. https://doi.org/10.1097/MLR.0000000000000625

12.

Frazer

McConnell

Jansson

L. M.

(2019). Treatment for substance usedisorders in pregnant women: Motivators and barriers. Drug and Alcohol Dependence, 205, Article107652. https://doi.org/10.1016/j.drugalcdep.2019.107652

13.

Hirschfeld Davis

. (2017, October 26). Trump declares opioid crisis a “health emergency” but requests no funds. New York Times. https://www.nytimes.com/2017/10/26/us/politics/trump-opioid-crisis.html

14.

Greenwald

(2009). Drug decriminalization in Portugal: Lessons for creating fair and successful drug policies. CATO Institute.

15.

Grella

C. E.

Gil-Rivas

Cooper

(2004). Perceptions of mental health and substance abuse program administrators and staﬀ on service delivery to persons with cooccurring substance abuse and mental disorders. Journal of Behavioral Health Services & Research, 31(1), 38-49. https://doi.org/10.1007/BF02287337

16.

Guttmacher Institute. (2020). Substance abuse during pregnancy. https://www.guttmacher.org/state-policy/explore/substance-use-during-pregnancy

17.

Jilani

S. M.

Frey

M. T.

Pepin

Jewell

Jordan

Miller

A. M.

Robinson

St. Mars

Bryan

J. Y.

Ailes

E. C.

McCord

R. F.

Gilchrist

Foster

Lind

J. N.

Culp

Penn

M. S.

Reefhuis

(2019). Evaluation of state-mandated reporting of neonatal abstinence syndrome—six states, 2013–2017. Morbidity and Mortality Weekly Report, 68(1), 6-10. https://doi.org/10.15585/mmwr.mm6801a2

18.

Jones

H. E.

Kaltenbach

Heil

S. H.

Stine

S. M.

Coyle

M. G.

Arria

A. M.

O’Grady

K. E.

Selby

Martin

P. R.

Fischer

(2010). Neonatal abstinence syndrome after methadone or buprenorphine exposure. New England Journal of Medicine, 363(24), 2320-2331. https://doi.org/10.1056/NEJMoa1005359

19.

Kampman

Jarvis

(2015). American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use. Journal of Addiction Medicine, 9(5), 358-367. https://doi.org/10.1097/ADM.0000000000000166

20.

Kolodny

Courtwright

D. T.

Hwang

C. S.

Kreiner

Eadie

J. L.

Clark

T. W.

Alexander

G. C

. (2015). The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction. Annual Review of Public Health, 36(1), 559-574. https://doi.org/10.1146/annurev-publhealth-031914-122957

21.

Kozhimannil

K. B.

Graves

A. J.

Levy

Patrick

S. W.

(2017). Nonmedical use of prescription opioids among pregnant us women. Women’s Health Issues, 27(3), 308-315. https://doi.org/10.1016/j.whi.2017.03.001

22.

Maeda

Bateman

B. T.

Clancy

C. R.

Creanga

A. A.

Leffert

L. R.

(2014). Opioid abuse and dependence during pregnancy temporal trends and obstetrical outcomes. Journal of the American Society of Anesthesiologists, 121(6), 1158-1165. https://doi.org/10.1097/ALN.0000000000000472

23.

National Survey on Drug Use and Health. (2018). What is NSDUH? https://nsduhweb.rti.org/respweb/homepage.cfm

24.

Patrick

S. W.

Dudley

Martin

P. R.

Harrell

F. E.

Warren

M. D.

Hartmann

K. E.

Ely

E. W.

Grijalva

C. G.

Cooper

W. O.

(2015). Prescription opioid epidemic and infant outcomes. Pediatrics, 135(5), 842-850. https://doi.org/10.1542/peds.2014-3299

25.

Qato

D. M.

Zhang

Gandhi

A. B.

Simoni-Wastila

Coleman-Cowger

V. H.

(2020). Co-use of alcohol, tobacco, and licit and illicit controlled substances among pregnant and nonpregnant women in the United States: Findings from 2006 to 2014 National Survey on Drug Use and Health (NSDUH) data. Drug and Alcohol Dependence, 206, Article 107729. https://doi.org/10.1016/j.drugalcdep.2019.107729

26.

RTI International. (2015). 2016 National Survey on Drug Use and Health: Field interviewer manual field interviewer computer manual. https://www.samhsa.gov/data/sites/default/files/reports/rpt23261/NSDUHmrbFIManual2020.pdf

27.

Rudd

R. A.

Aleshire

Zibbell

J. E.

Matthew Gladden

(2016). Increases indrug and opioid overdose deaths—United States, 2000–2014. American Journal of Transplantation, 16(4), 1323-1327. https://doi.org/10.1111/ajt.13776

28.

Saia

K. A.

Schiff

Wachman

E. M.

Mehta

Vilkins

Sia

Samura

DeAngelis

Jackson

C. V.

Emmer

S. F.

Shaw

Bagly

(2016). Caring for pregnant women with opioid use disorder in the USA: Expanding and improving treatment. Current Obstetrics and Gynecology Reports, 5(3), 257-263. https://doi.org/10.1007/s13669-016-0168-9

29.

Sharma

Bruner

Barnett

Fishman

(2016). Opioid use disorders. Child and Adolescent Psychiatric Clinics of North America, 25(3), 473-487. https://doi.org/10.1016/j.chc.2016.03.002

30.

Substance Abuse and Mental Health Services Administration. (2016). A collaborative approach to the treatment of pregnant women with opioid use disorders (HHS Publication No. SMA 16-4978). https://ncsacw.samhsa.gov/files/Collaborative_Approach_508.pdf

31.

Substance Abuse and Mental Health Services Administration. (2018). Clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants (HHS Publication No. SMA 18-5054). https://store.samhsa.gov/sites/default/files/d7/priv/sma18-5054.pdf

32.

Substance Abuse and Mental Health Services Administration. (2019). Series, TIP 35: Enhancing motivation for change in substance use disorder treatment. https://store.samhsa.gov/product/TIP-35-Enhancing-Motivation-for-Change-in-Substance-Use-Disorder-Treatment/PEP19-02-01-003

33.

U.S. Department of Health and Human Services. (2018). HHS provides states second installment of grant awards to combat opioid crisis. https://www.hhs.gov/about/news/2018/04/18/hhs-provides-states-second-installment-grant-awards-combat-opioid-crisis.html

34.

Wachman

E. M.

Schiff

D. M.

Silverstein

(2018). Neonatal abstinence syndrome: Advances in diagnosis and treatment. JAMA Journal of the American Medical Association, 319(13), 1362-1374. https://doi.org/10.1001/jama.2018.2640

35.

L. T.

Zhu

Swartz

M. S.

(2016). Treatment utilization among persons with opioid use disorder in the United States. Drug and Alcohol Dependence, 169, 117-127. https://doi.org/10.1016/j.drugalcdep.2016.10.015